Tata India Pharma & Healthcare Fund vs Quant Healthcare Fund Regular compare
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Quant Healthcare Fund Regular - Growth
Chart Comparison
Overview
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Fund | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1325 Cr | ₹402 Cr |
| Min Investment | ₹5000 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹1000 |
| Min Addl Investment | ₹1000 | ₹1000 |
| Launch Date | 28 Dec 2015 | 17 Jun 2023 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | Nifty Pharma TRI | BSE Healthcare TRI |
| Turn Over | 26.49% | % |
| Expense Ratio | 2.14 | 2.39 |
| Manager | Meeta Shetty | Sanjeev Sharma |
| ISIN Code | INF277K016A9 | INF966L01CG3 |
| Exits Load | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 | Quant Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 15 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Month | -1.17% | -2.23% |
| 6 Month | 3.79% | -3.14% |
| 1 Year | -0.34% | -7.47% |
| 3 Year | 21.48% | - |
| 5 Year | 16.15% | - |
SIP Return Analysis
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 6 Month | 0.51% | -1.67% |
| 1 Year | 6.3% | 1.27% |
| 3 Year | 17.98% | - |
| 5 Year | 17.13% | - |
Rolling Lumpsum Returns
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| 1 Year | 8.63% | 11.19% |
| 3 Year | 18.84% | - |
| 5 Year | 15.73% | - |
Risk Management
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Standard Deviation | 16.04% | - |
| Sharp | 0.90% | - |
| Beta | 0.97% | - |
| Alpha | -0.83% | - |
Fund Managers
| Scheme Name | Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Name | Meeta Shetty | Sanjeev Sharma |
| Total AUM | ₹17847 Cr | ₹39731 Cr |
| Funds Managed | 5 | 22 |
| Tata India Pharma & Healthcare Fund-Regular Plan-Growth | Quant Healthcare Fund Regular - Growth |
Market Cap
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 3.86 | 35.19 |
| Mid Cap | 38.84 | 12.16 |
| Small Cap | 34.36 | 39.53 |
| Large Cap | 22.93 | 13.12 |
Sector Allocation
| Scheme Name |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Quant Healthcare Fund Regular - Growth |
|---|---|---|
| Others | 1.5 | 21.05 |
| Healthcare | 96.33 | 62.04 |
| Basic Materials | 2.17 | - |
| Financial Services | 0 | 0 |
| Energy | - | 6.14 |
| Real Estate | - | 2.8 |
| Consumer Defensive | - | 7.97 |
Top Comparisons
DSP Short Term Fund - Regular Plan - Growth
3Y Returns7.25%
Baroda BNP Paribas Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.46%
Franklin India Technology Fund-Growth
3Y Returns21.88%
Aditya Birla Sun Life Digital India Fund - Growth - Regular Plan
3Y Returns12.9%
ICICI Prudential Retirement Fund - Pure Equity - Growth Option
3Y Returns22.91%
HDFC Retirement Savings Fund - Equity Plan - Growth Option
3Y Returns17.46%
HSBC Consumption Fund - Regular (G)
3Y Returns0%
Mirae Asset Great Consumer Fund - Regular Plan - Growth option
3Y Returns16.11%